Dr. Peter Earl Clark, MD

Dr. Clark practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Clark's NPI, 1073595401, was assigned on November 21, 2005. Dr. Clark graduated from Harvard Medical School in 1994. Dr. Clark holds North Carolina license 200200506.

Dr. Clark's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Clark's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Clark is also affiliated with Atrium Health Pineville. The medical group on file is Atrium Health Levine Children's Gastroenterology. Dmand AI also links Dr. Clark to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clark practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Clark's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Clark is board certified in urology by the American Board of Urology. Dmand AI has Dr. Clark's licenses on file in 5 states: North Carolina, California, South Carolina, Tennessee and Ohio.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, prostate cancer, transurethral procedures, urinary endoscopy and UTI among the conditions Dr. Clark treats.

CMS data shows 542 Medicare services from Dr. Clark across 10 procedure codes in 2024, for 227 Medicare patients. Medicare paid $35,618 for them.

CMS counts 227 Medicare patients who saw Dr. Clark in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clark's median patient age at 74, with 32% women.

In 2024, Dr. Clark wrote 263 Medicare Part D claims for 80 patients. 83% of them were for generic drugs. CMS names the drug for 202 of them, across 8 drugs with 11 or more claims each, at $17,885 in total drug cost. In 2023, CMS named 135 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Clark for performance year 2024, reported as part of a group. Dr. Clark accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clark as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 172 papers to Dr. Clark, published from 2005 to 2024. 2021 was the busiest year, with 11. The most frequent topics are Urinary Bladder Neoplasms, Kidney Neoplasms and Cystectomy. Dr. Clark has published most often in J Urol. Dr. Clark's most frequent co-authors are Sam S. Chang, MD, Michael Cookson, MD and Kris Gaston, MD.

Dmand AI links Dr. Clark to 3 clinical trials. Conditions studied include Carcinoma, Carcinoma, Renal Cell and Urinary Bladder Neoplasms.

CMS Open Payments shows 48 general payments to Dr. Clark from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. Urogen Pharma, Inc. paid the most, $4,319.

Dmand AI lists 1 award for Dr. Clark, most recently CMS Stage 1 2012 in 2012.

Dr. Clark graduated from Harvard Medical School in 1994.

Dr. Clark is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.